Q1 and FY consensus estimates
Estimates for Q1 and FY 2020/21 based on median.
| Q1 2020/21 | FY 2020/21 | |||||||
| DKKm | Low | Consensus | High | Low | Consensus | High | ||
| Revenue |
802 |
881 | 987 | 4,016 | 4,186 | 4,329 | ||
| Gross profit |
492 |
546 | 599 |
2,454 |
2,632 | 2,802 | ||
| Gross margin |
60.3% |
61.5% | 63.5% |
61.1% |
62.6% | 65.5% | ||
| EBIT before special items |
20 |
54 | 88 | 436 | 490 | 529 | ||
| EBIT margin before special items |
2.3% |
6.0% | 10.0% | 10.8% | 11.6% | 12.3% | ||
| Net profit |
4 |
32 | 59 | 244 | 332 | 395 | ||
| Net profit margin |
0.5% |
3.6% | 6.3% | 6.1% | 7.7% | 9.3% | ||
| Endoscopes sold (units) | 225,000 | 270,000 | 354,000 |
1,261,000 |
1,358,820 | 1,464,950 | ||
| Organic growth | 9.0% | 18.4% | 33.0% |
16.6% |
19.2% | 23.9% |
12 January 2021, based on estimates from 11 analysts.
